Baer Law Blog - Latest Updates

Pharmacists Must Ensure Prescription Orders are Issued for a Legitimate Medical Purpose by an Authorized Prescriber and Have a Recognized Medical Utility or Application

As discussed previously on the Baer Law Blog, corresponding responsibility remains one of the most misunderstood or unknown…

Read More

Countdown to October 6, 2014: Hydrocodone Containing Product Reclassification

As discussed previously here on the Baer Law Blog, after more than a decade of debate, hydrocodone…

Read More

Notice to Florida Licensed Non-Resident Pharmacies

Beginning October 1, 2014, Florida requires all non-resident pharmacies to obtain a Nonresident Sterile Compounding Permit in…

Read More

Updated Controlled Substances Disposal Requirements: Effective October 9, 2014

Historically, under the Controlled Substance Act (CSA), patients could only dispose of unused controlled substances themselves or…

Read More

Disposing of Unused Controlled Substances: DEA Expands Prescription Drug Take-Back

In early October, disposing of unused medications, including controlled substances, will likely get much easier as the…

Read More

Hydrocodone Combination Products Moving to Schedule II

On August 22, the Drug Enforcement Agency (DEA) published a final rule to move hydrocodone combination products…

Read More

FDA's Guidance on Compounding for Human Use

As discussed previously on the Baer Law Blog, Title I of the Drug Quality and Security Act…

Read More

Notice to All Licensed Colorado Pharmacists and Registered DEA Prescribing Practitioners

All Colorado licensed pharmacists and registered DEA prescribing practitioners are required to register an individual user account…

Read More

Colorado State Board of Pharmacy Legislation Update No. 2

HB14-1083 – Acute Treatment Units Stock Medications HB14-1083 – Acute treatment units (ATU) provide medically supervised behavioral health treatment…

Read More

Colorado State Board of Pharmacy Legislation Update: Modifications to the Electronic Prescription Drug Monitoring Program

HB14-1283 – Modify Prescription Drug Monitoring Program HB14-1283 makes the following modifications to the electronic prescription drug…

Read More